PulseSight, EURETINA에서 PST-611 1상 초기 임상 효능 데이터 발표, 건성 AMD/지리적 위축 치료 잠재적 돌파구 제시

The Manila Times · 2026.10.07 16:03 · 원문 사이트

🇰🇷 한글 번역

PulseSight, EURETINA에서 PST-611의 1상 초기 임상 효능 데이터 발표, 건성 AMD/지리적 위축 치료에 잠재적 돌파구 제시 마닐라 타임스

📄 원문 (English)

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy    The Manila Times

▶ 칩 라이브 24 홈으로 — chiplive24.com

다른 반도체 뉴스

Is Micron a Buy After Its Latest Explosive Earnings Report? Here Are the Bull and Bear Cases. · Yahoo Finance Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy. · Yahoo Finance Samsung Electronics to Pay Special Performance Bonuses to Semiconductor Employees in Late March Next Year Subject to 49.5% Tax Rate · news.sbs.co.kr Intel to continue working on Musk’s Terafab despite TSMC talks - Bloomberg · Yahoo Finance The #AIPulse: * SpaceX seeks $40 bn to buy Nvidia chips, with Apollo expected to lead funding * Meta, Walmart, Stripe & Shopify back a standard for AI agents * OpenAI plans invisible watermarks for ChatGPT and Codex text in the EU Rachna D. #AIPulse #Ar · LinkedIn AMD Crossed $600, So Does Meta Get 160 Million AMD Shares For Free Now? · Yahoo Finance Prediction: A $1,000 Investment in Qualcomm Today Could Be Worth This Much by 2030 as AI Moves to the Edge · Yahoo Finance NVIDIA (NVDA) vs. Apple (AAPL): Which Stock Wins the Valuation Race? · Yahoo Finance